Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-032095
Filing Date
2019-06-24
Accepted
2019-06-24 18:23:33
Documents
1
Period of Report
2019-06-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv524091_4.html 4  
1 OWNERSHIP DOCUMENT tv524091_4.xml 4 7722
  Complete submission text file 0001144204-19-032095.txt   9765
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 19916398

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 19916399